Acadia Pharmaceuticalshttps://acadia.com/

Your landing page’s weakest score is Trust.

How Acadia Pharmaceuticals ranks

  1. 1.Acadia Pharmaceuticals65
  2. 2.Ultragenyx61
  3. 3.Neurogene52
  4. 4.Taysha Gene Therapies48
  5. 5.Uncommon Therapeutics47
Fix Trust
65Growth scoreupdated

category scores

Trust52Value props58
category scoresShowHide
Trust52Value props58

Trust

52Fair

Proof that the product is real, competent, and safe to try.

Trust read
Acadia PharmaceuticalsNav links to "Investors," "Pipeline," and "Healthcare Professionals" signaling an established public pharma company
Uncommon Therapeutics"First indication: Rett Syndrome" line naming a specific disease program
Taysha Gene TherapiesNo visible trust signal identified.
NeurogeneNo visible trust signal identified.
UltragenyxNo visible trust signal identified.

Value props

58Fair

Title, subtitle, hero — do they sell the product's true value?

Acadia Pharmaceuticals’s headline vagueTurning scientific promise into meaningful innovationWe make the difference for underserved neurological and rare disease communities around the world.

Working

  • Subhead names rare-disease focus
  • Hero image shows patient community
  • Clear CTA to pipeline

Could improve

  • H1 is generic pharma abstraction
  • No numbers or proof points
  • No named medicines or areas

Information hierarchy

72Fair

Does the design help or inhibit what the page is trying to say?

Acadia Pharmaceuticals desktop capture for Information hierarchy

What works

What to improve

CTA

72Fair

Copy, size, verb, cost-feel — does the primary CTA earn the click?

Acadia Pharmaceuticals

How Acadia Pharmaceuticals compares

Recommended rewrites

Mobile web

72Fair

The phone experience as a first-class citizen.

Acadia Pharmaceuticals mobile capture for Mobile web

What works

What to improve